Skip to main content
KOLON LIFE SCIENCE Inc. logo

KOLON LIFE SCIENCE Inc. — Investor Relations & Filings

Ticker · 102940 ISIN · KR7102940004 KO Manufacturing
Filings indexed 297 across all filing types
Latest filing 2026-02-20 Legal Proceedings Report
Country KR South Korea
Listing KO 102940

About KOLON LIFE SCIENCE Inc.

https://www.kolonls.co.kr/

KOLON LIFE SCIENCE Inc. is a company operating through two primary business divisions: Bio and Chemical. The Bio division is a clinical-stage biotechnology unit focused on developing novel cell and gene therapies, with a pipeline that includes treatments for neuropathic pain and oncolytic virus therapies for cancer. The Chemical division develops, manufactures, and sells Active Pharmaceutical Ingredients (APIs), specialty chemicals, antimicrobials, and water treatment solutions. The company leverages its expertise in both biotechnology and chemical manufacturing to provide advanced healthcare and environmental products.

Recent filings

Filing Released Lang Actions
[기재정정]소송등의제기ㆍ신청(일정금액이상의청구)
Legal Proceedings Report Classification · 100% confidence The document is a regulatory filing from Kolon Life Science regarding a 'Lawsuit/Legal Proceeding' (소송등의제기ㆍ신청). It details a correction (정정신고) to a previously filed lawsuit disclosure, specifically updating the number of plaintiffs and the total claim amount. Since this document pertains to ongoing legal proceedings and litigation updates, it falls under the 'Legal Proceedings Report' category.
2026-02-20 Korean
지급수단별ㆍ지급기간별지급금액및분쟁조정기구에관한사항
Regulatory Filings Classification · 95% confidence The document is a regulatory disclosure regarding payment methods, payment periods, and dispute resolution mechanisms under the Fair Transactions in Subcontracting Act (Article 13-3). It is a specific, structured regulatory filing required by Korean law for corporate transparency, which does not fit into categories like financial reports, earnings releases, or shareholder communications. Therefore, it is classified as a general regulatory filing.
2026-02-13 Korean
소송등의판결ㆍ결정(일정금액이상의청구)
Legal Proceedings Report Classification · 100% confidence The document is a formal regulatory disclosure regarding a court judgment on a lawsuit involving a significant claim amount (over 19 billion KRW). It details the case name, the court's decision to dismiss the plaintiffs' claims, and the company's planned legal response. This fits the definition of a Legal Proceedings Report (LTR) as it pertains to significant litigation and regulatory/judicial outcomes.
2026-02-06 Korean
투자판단관련주요경영사항 (형사재판 2심 판결 결과)
Legal Proceedings Report Classification · 95% confidence The document is a formal disclosure regarding the outcome of a criminal trial (2nd instance) involving the company and its former CEO. It details legal proceedings, court case numbers, and judicial outcomes. Since this pertains to significant legal matters and regulatory disclosures regarding litigation, it falls under the 'Legal Proceedings Report' category.
2026-02-06 Korean
소송등의판결ㆍ결정(일정금액이상의청구)
Legal Proceedings Report Classification · 100% confidence The document is a formal regulatory disclosure from Kolon Life Science regarding a court judgment on a damages lawsuit. It details the case name, the court's decision (dismissal of claims), the amount involved, and the company's future legal strategy. This fits the definition of a Legal Proceedings Report (LTR) as it concerns significant litigation and regulatory/court outcomes.
2026-02-06 Korean
소송등의제기ㆍ신청(일정금액이상의청구)
Legal Proceedings Report Classification · 100% confidence The document is a formal regulatory disclosure from Kolon Life Science regarding the filing of a lawsuit (damages claim) against the company. It details the plaintiff, the claim amount, the legal context, and the company's planned response. This falls under the category of legal proceedings and litigation disclosures.
2026-02-05 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.